Few & Far Between: Conversations from the Front Lines of Drug Development

Epsiode 50: Jonathan Rigby, Chairman and CEO, Sernova


Listen Later

Now on the Few & Far Between podcast:

Did you know that one in ten people with Type 1 Diabetes (TD1) die from hypoglycemia? Today's guest, who has TD1, explains how he turned his passion for helping others into innovative treatments for diabetes and other chronic diseases.

Host Chris O'Brien welcomes Jonathan Rigby, Chairman and CEO at Sernova, to the podcast. Listen in as we spotlight Jonathan's 30-year industry journey, the development of implantable bio-hybrid organs, and how to plan for your first 30 days in a new biotech role.

Tune in today!

...more
View all episodesView all episodes
Download on the App Store

Few & Far Between: Conversations from the Front Lines of Drug DevelopmentBy Chris O'Brien

  • 5
  • 5
  • 5
  • 5
  • 5

5

12 ratings


More shows like Few & Far Between: Conversations from the Front Lines of Drug Development

View all
The Readout Loud by STAT

The Readout Loud

316 Listeners